**Specifications Table**TableSubject area*Renal Physiology*More specific subject area*Renal biomarkers serum creatinine (Scr) and serum cystatin C (ScysC) and their relation with directly measured glomerular filtration rate (mGFR)*Type of data*Assay results for serum creatinine, serum cystatin C and directly measured glomerular filtration rate from various reference methods, demographic data*How data was acquired*Diagnostic assays, accepted reference methods for GFR*Data format*Data are presented in graphs and tables in analyzed format*Experimental factors*All biomarker assays are calibrated against the international standard or gold standard method (IDMS for Scr). All methods for GFR are reference methods with accepted sufficient accuracy.*Experimental features*See Table 1 in reference*[@bib1].Data source location*See Table 2 in reference*[@bib1]*. All data cohorts were presented in previous studies.*Data accessibility*The data used in this article are obtained by pooling different cohorts which are not available in a public repository, and were received by the mentioned institutes for the purpose of this study. The data from the CRIC Study reported here were supplied by the NIDDK Central Repositories.*[@bib1]*The data are presented in summary tables and graphs within this article.*

**Value of the data**•The data present the rationale for the choice of the rescaling factor for serum cystatin C.•Rescaling brings the biomarker to a notionally common scale making its interpretation easy with reference to the reference interval \[0.67--1.33\].•The upper limit of the reference interval (1.33) is used as a threshold to detect impaired kidney function and this is compared to the definition of impaired kidney function based on a fixed and age-dependent threshold for GFR.•These data give new insights into the relation between renal biomarkers and measured GFR.

1. Data {#s0005}
=======

1.1. Rationale for the rescaling of serum cystatin C (ScysC) {#s0010}
------------------------------------------------------------

Analogous to the normalization or rescaling of serum creatinine (Scr), the normalization or rescaling factor(s) for ScysC is defined as the mean (or median) of the ScysC-distribution(s) for healthy subjects. The rescaling factors have previously been defined as Q~cysC~ = 0.82 mg/L for subjects aged \< 70 years and Q~cysC~ = 0.95 mg/L for subjects aged ≥ 70 years [@bib2]. In this article, data and a new analysis are presented to further support these choices for the rescaling of ScysC.

Only 'healthy' subjects were selected, that is, a subgroup is selected from the total collection of 8584 subjects, obtained from the normal population and from nephrology clinics. First, it was required that Scr/Q~crea~ ≤ 1.33, or, only subjects with 'normal' Scr-values were selected. Q~crea~-values for Scr have been reported for children and adolescents [@bib3], [@bib4]. For adults, Q~crea~ = 0.70 mg/dL is used for females and Q~crea~ = 0.90 mg/dL for males. This selection requirement reduces the total dataset from 8584 to 5352 patients. The additional requirement that mGFR ≥ 60 mL/min/1.73 m² further reduces the dataset from 5352 to 4907. [Table 1](#t0005){ref-type="table"} shows the numbers, mean, median, standard deviation (SD) and interquartile range (IQR) per age-decade for ScysC in this healthy subjects subgroup.Table 1Serum cystatin C concentrations for subjects with Scr/Q~crea~ ≤ 1.33 and mGFR ≥ 60 mL/min/173 m².Table 1:Age GroupnmeanmedianSDIQR2--101700.940.920.180.2410--203520.960.930.220.2920--301220.840.810.170.1830--402930.790.780.140.1640--504320.810.800.160.2150--6015430.760.740.150.1760--7013170.810.780.160.1970--805280.890.880.150.1980--901470.960.960.140.19\> 9031.041.010.060.114907

For each decade, a truncated cumulative Gaussian fit was performed to determine the mean and standard deviation of the sample ([Fig. 1](#f0005){ref-type="fig"} and [Table 1](#t0005){ref-type="table"}). The dotted line in [Fig. 1](#f0005){ref-type="fig"} represents the linear increase in normalization factor beyond the age of 70 years. In the FAS-cystatin C article [@bib2] it was shown that there was no added value to using this (dotted) straight line fit for the normalization factor beyond 70 years, therefore, to keep it simple, the value of 0.95 mg/L was chosen as the rescaling factor for ScysC for ages \> 70 years.Fig. 1: Mean and reference intervals for serum cystatin C (mg/L) for age decades (years). The solid horizontal line corresponds with the choice of the normalization factor, 0.82 up to 70 years and 0.95 beyond 70 years of age. The vertical bars represent the interval from 2.5th Percentile (Pct) to 97.5th Pct as obtained from the Gaussian distribution for each decade.Fig. 1

1.2. Rescaled biomarkers {#s0015}
------------------------

The FAS-equation has been designed for Scr/Q~crea~ but it has recently been shown that it can also be used for ScysC/Q~cysC~ and for the combination of both normalized biomarkers [@bib2], [@bib5]. The fact that the same equation can be used to estimate mGFR from renal biomarkers also means that it is expected that Scr/Q~crea~ ≈ ScysC/Q~cysC~.

[Fig. 2](#f0010){ref-type="fig"} is a scatterplot of ScysC/Q~cysC~ against Scr/Q~crea~, using the corresponding age/sex dependent Q~crea~-values and Q~cysC~-values, for all 8584 subjects. The diagonal line is the identity line, representing equal rescaled biomarkers. The scatter around the identity line indicates the amount to which the rescaled biomarkers deviate from each other. The overall Pearson correlation coefficient (r) between the rescaled biomarkers is 0.87 (p \< 0.0001, n = 8584) and Lin\'s Concordance Correlation Coefficient is 0.857 with 95%CI \[0.852--0.863\]. Lin\'s CCC evaluates the degree to which pairs of observations fall on the diagonal or identity line through the origin. For children, r = 0.85, Lin\'s CCC = 0.828 (n = 767); for adults, r = 0.87 and Lin\'s CCC = 0.861 (n = 6068) and for older adults r = 0.88, Lin\'s CCC = 0.852 (n = 1749).Fig. 2: Rescaled biomarker ScysC/Q~cysC~ against Scr/Q~crea~ for n=8584 subjects. The diagonal line is the identity line. The vertical and horizontal dotted lines correspond to ScysC/Q~cysC~ and Scr/Q~crea~ equal to 0.67 and 1.33 respectively and define the area of 'normal' biomarkers. Rescaled biomarker values \< 0.67 are 'Low' and \> 1.33 are indicated as 'high'.Fig. 2

1.3. diagnostic value of the single rescaled biomarkers {#s0020}
-------------------------------------------------------

The diagnostic value of the single renal biomarkers is presented in the [Table 2a](#t0010){ref-type="table"}, [Table 3a](#t0020){ref-type="table"}. The fixed threshold for mGFR of 60 mL/min/1.73 m² is compared to the age-dependent threshold CO~AD~ = 107.3/1.33 \[ × 0.988^(Age-40)^ if Age \> 40 years\] [@bib1], [@bib6].Table 2aFrequency of patients with rescaled Serum creatinine ≤ and \> 1.33 in the subgroups defined by mGFR (fixed and age-dependent threshold CO~AD~).Table 2a:Scr/Q~crea~ ≤ 1.33Scr/Q~crea~ \> 1.33Age GroupmGFR\< 60mGFR≥ 60mGFR\<CO~AD~mGFR≥CO~AD~TotalmGFR\< 60mGFR≥ 60mGFR\<CO~AD~mGFR≥CO~AD~TotalGrand Total\[2--10\[0170201501702848611576246\[10--20\[6352682903581479421526241599\[20--30\[41221910712672298516101227\[30--40\[1293272672941519420540245539\[40--50\[174327037944922712529755352801\[50--60\[61154310514991604385142441865272131\[60--70\[1031317111130914206831686811708512271\[70--80\[13952857610667554644801386181285\[80--90\[96147232202431801015337190433≥ 901735152032027532524444907505484653512459774264558832338584Table 2bFrequency of patients with rescaled Serum cystatin C ≤ and \> 1.33 in the subgroups defined by mGFR (fixed and age-dependent threshold CO~AD~).Table 2b:ScysC/Q~cysC~ ≥ 1.33ScysC/Q~cysC~ \> 1.33Age GroupmGFR\< 60mGFR≥ 60mGFR\<CO~AD~mGFR≥CO~AD~TotalmGFR\< 60mGFR≥ 60mGFR\<CO~AD~mGFR≥CO~AD~TotalGrand Total\[2--10\[1157201381582761612788246\[10--20\[52853925129014816124465309599\[20--30\[4133241131377218801090227\[30--40\[7352622973591453517010180539\[40--50\[225001034195222225726415279801\[50--60\[5315951101538164839390436474832131\[60--70\[1131352122134314656731336701368062271\[70--80\[22957010369679946422434524861285\[80--90\[9415222224246182515433187433≥ 901433141735029635525425099608503356412361582254240129438584

### 1.3.1. Serum creatinine {#s0025}

Sensitivity (S) and Specificity (Sp) in [Fig. 3](#f0015){ref-type="fig"}a-b are calculated as follows:a)in case a true positive test result is defined as Scr/Q~crea~ \> 1.33 in the mGFR \< 60 subgroup, and a true negative test result is defined as Scr/Q~crea~ ≤ 1.33 in the mGFR ≥ 60 subgroup. E.g. in the age-group 2--10 years, S = 28 / (28 + 0) = 100% and Sp = 170 / (170 + 48) = 78.0%; in the age-group 80--90 years, S = 180 / (180 + 96) = 65.2% and Sp = 147 / (147 + 10) = 93.6%. Reversing the role of Scr/Q~crea~ and mGFR, we find for the 2--10 year age-group: S = 28/76 = 36.8% and Sp = 170/170 = 100%; in the age-group 80--90 years, we have S = 180/190 = 94.7% and Sp = 147/243 = 60.5%.b)in case a true positive test result is defined as Scr/Q~crea~ \> 1.33 in the mGFR \< CO~AD~ subgroup, and a true negative test result is defined as Scr/Q~crea~ ≤ 1.33 in the mGFR ≥ CO~AD~ subgroup. E.g. in the age-group 2--10 years, S = 61 / (61 + 20) = 75.3% and Sp = 220 / (220 + 37) = 85.6%; in the age-group 80--90 years, S = 180 / (180 + 96) = 65.2% and Sp = 147 / (147 + 10) = 93.6%. Reversing the role of Scr/Q~crea~ and mGFR, we find for the 2--10 year age-group: S = 61/76 = 80.3% and Sp = 150/170 = 88.2%; in the age-group 80--90 years, we have S = 153/190 = 80.5% and Sp = 220/243 = 90.5%.Fig. 3**a**: Sensitivity and Specificity per age-category. Solid circles correspond to Scr/Q~crea~ as the test result (positive when \> 1.33, negative when ≤ 1.33) and diseases status defined by the fixed mGFR threshold of 60 mL/min/1.73 m². Open circles correspond to the reversed situation, that is, mGFR as the test result (positive when mGFR \< 60 and negative when mGFR ≥ 60) and disease status defined by the Scr/Q~crea~ threshold of 1.33. **b**: Sensitivity and Specificity per age-category. Solid circles correspond to Scr/Q~crea~ as the test result (positive when \> 1.33, negative when ≤ 1.33) and diseases status defined by the age-dependent mGFR threshold CO~AD~. Open circles correspond to the reversed situation, that is, mGFR as the test result (positive when mGFR \< CO~AD~ and negative when mGFR ≥ CO~AD~) and disease status defined by the Scr/Q~crea~ threshold of 1.33.Fig. 3

### 1.3.2. Serum cystatin C {#s0030}

Sensitivity (S) and Specificity (Sp) are calculated as follows:a)in case a true positive test result is defined as ScysC/Q~cysC~ \> 1.33 in the mGFR \< 60 subgroup, and a true negative test result is defined as ScysC/Q~cysC~ ≤ 1.33 in the mGFR ≥ 60 subgroup. E.g. in the age-group 2--10 years, S = 27 / (27 + 1) = 96.4% and Sp = 157 / (157 + 61) = 72.0%; in the age-group 80--90 years, S = 182 / (182 + 94) = 65.9% and Sp = 152 / (152 + 5) = 96.8%. Reversing the role of ScysC/Q~cysC~ and mGFR, we find for the 2--10 year age-group: S = 27/88 = 30.7% and Sp = 285/290 = 98.3%; in the age-group 80--90 years, we have S = 182/187 = 97.3% and Sp = 152/246 = 61.8%.b)in case a true positive test result is defined as ScysC/Q~cysC~ \> 1.33 in the mGFR \< CO~AD~ subgroup, and a true negative test result is defined as ScysC/Q~cysC~ ≤ 1.33 in the mGFR ≥ CO~AD~ subgroup. E.g. in the age-group 2--10 years, S = 61 / (61 + 20) = 75.3% and Sp = 138 / (138 + 27) = 83.6%; in the age-group 80--90 years, S = 154 / (154 + 22) = 87.5% and Sp = 224 / (224 + 33) = 87.2%. Reversing the role of ScysC/Q~cysC~ and mGFR, we find for the 2--10 year age-group: S = 61/88 = 69.3% and Sp = 138/158 = 87.3%; in the age-group 80--90 years, we have S = 154/187 = 82.4% and Sp = 224/246 = 91.1% ([Fig. 4](#f0020){ref-type="fig"}).Fig. 4**a**: Sensitivity and Specificity per age-category. Solid circles correspond to ScysC/Q~cysC~ as the test result (positive when \> 1.33, negative when ≤ 1.33) and disease status defined by the fixed mGFR threshold of 60 mL/min/1.73 m². Open circles correspond to the reversed situation, that is, mGFR as the test result (positive when mGFR \< 60 and negative when mGFR ≥ 60) and disease status defined by the ScysC/Q~cysC~ threshold of 1.33. **b**: Sensitivity and Specificity per age-category. Solid circles correspond to ScysC/Q~cysC~ as the test result (positive when \> 1.33, negative when ≤ 1.33) and diseases status defined by the age-dependent mGFR threshold CO~AD~. Open circles correspond to the reversed situation, that is, mGFR as the test result (positive when mGFR \< CO~AD~ and negative when mGFR ≥ CO~AD~) and disease status defined by the ScysC/Q~cysC~ threshold of 1.33.Fig. 4

1.4. Interchangeability between biomarkers and mGFR / FAS-eGFR {#s0035}
--------------------------------------------------------------

Comparing (Scr/Q~crea~+ScysC/Q~cysC~)/2 using the threshold of 1.33 with mGFR using the fixed threshold of 60 mL/min/1.73 m², for the complete n = 8584 dataset, to detect renal impairment, we have ([Table 3a](#t0020){ref-type="table"}):Table 3a2×2 frequency table comparing measured GFR (with fixed threshold of 60 mL/min/1.73 m²) with the average of the biomarkers (with threshold 1.33).Table 3amGFR**≥ 60\< 60TotalAverage of Biomarkers≤ 1.33**50674155482**\> 1.33**61424883102**Total**568129038584

Exact McNemar\'s test: p \< 0.0001. % agreement = (5067 + 2488) / 8584 = 88.0%.

Comparing (Scr/Q~crea~+ScysC/Q~cysC~)/2 using the threshold of 1.33 with mGFR using an age-dependent threshold, for the complete n = 8584 dataset, to detect renal impairment, we have ([Table 3b](#t0025){ref-type="table"}):Table 3b2×2 frequency table comparing measured GFR (with age-dependent threshold) with the average of the biomarkers (with threshold 1.33).Table 3bmGFR**≥ CO**~**AD**~**\< CO**~**AD**~**TotalAverage of Biomarkers≤ 1.33**50434395482**\> 1.33**39127113102**Total**543431508584

Exact McNemar\'s test: p = 0.1027. % agreement = (5043 + 2711) / 8584 = 90.3%.

Using the FAS~combi~ equation to calculate eGFR from both Scr/Q~crea~ and ScysC/Q~cysC~, the following table is obtained when comparing FAS-eGFR using the age-dependent threshold with the combined biomarker value (Scr/Q~crea~+ScysC/Q~cysC~)/2 using the threshold of 1.33 ([Table 4](#t0030){ref-type="table"}):Table 42×2 frequency table comparing (FAS) estimated GFR (with age-dependent threshold) with the average of the biomarkers (with threshold 1.33).Table 4FAS-eGFR**≥ CO**~**AD**~**\< CO**~**AD**~**TotalAverage of Biomarkers≤ 1.33**548205482**\> 1.33**031023102**Total**548231028584

In [Fig. 5](#f0025){ref-type="fig"}a-b, the raw mGFR-values are plotted against age, for the subgroups defined by (Scr/Q~crea~+ScysC/Q~cysC~)/2 below and above the threshold of 1.33, together with the fixed threshold for mGFR = 60 mL/min/1.73 m² and the age-dependent threshold obtained from the FAS-equation with (Scr/Q~crea~+ScysC/Q~cysC~)/2 = 1.33. These figures correspond to the [Table 3a](#t0020){ref-type="table"}, [Table 3b](#t0025){ref-type="table"}.Fig. 5**a-b**. Measured GFR against age for n = 5482 subjects with the mean of both biomarkers ≤1.33 (top), and n = 3102 with the mean of both biomarkers \>1.33 (bottom). The horizontal red line is the fixed GFR-threshold of 60 mL/min/1.73 m² and the curved red line is the age-dependent threshold CO~AD~.Fig. 5

2. Experimental design, materials and methods {#s0040}
=============================================

This is a retrospective study, where the data presented here were collected from 12 previously published cohorts (grand total of 8584 patients) and centralized for pooled data-analysis. Assay data for Scr and ScysC, together with measured GFR, age, sex were centralized for the data-analysis. The total number of patients was subdivided into subgroups corresponding with age-decades with the aim to perform a data-analysis of the diagnostic value (in terms of sensitivity and specificity) of the biomarkers per age-decade. Sensitivity and specificity were calculated with reference to measured GFR (fixed and age-dependent threshold), and with reference to the rescaled biomarker threshold of 1.33.

Scr was traceable to the gold standard Isotope Dilution Mass Spectrometry method, ScysC was obtained from assays calibrated to the international standard or ScysC was recalculated against the calibrator and measured GFR was obtained from accepted reference methods, as described in the main article [@bib1].

Transparency document. Supplementary material {#s0050}
=============================================

Supplementary material

The Chronic Renal Insufficiency Cohort Study (CRIC) was conducted by the CRIC Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The data from the CRIC Study reported here were supplied by the NIDDK Central Repositories. This manuscript was not prepared in collaboration with Investigators of the CRIC study and does not necessarily reflect the opinions or views of the CRIC study, the NIDDK Central Repositories, or the NIDDK.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2017.08.034](http://dx.doi.org/10.1016/j.dib.2017.08.034){#ir0005}.
